Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00773461
What this trial is testing

Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 209
Large-scale testing (Phase 3)Study completedNCT01353859
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 39
Post-approval studies (Phase 4)Study completedNCT00385671
What this trial is testing

An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Who this might be right for
Diabetic Neuropathy, Painful
Eli Lilly and Company 407
Large-scale testing (Phase 3)Looking for participantsNCT04221035
What this trial is testing

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Who this might be right for
High-Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris 800
Testing effectiveness (Phase 2)Looking for participantsNCT07284667
What this trial is testing

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Who this might be right for
Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc. 153
Large-scale testing (Phase 3)Study completedNCT01197521
What this trial is testing

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 923
Testing effectiveness (Phase 2)Study completedNCT02640625
What this trial is testing

Improving Prognosis in HIV Infection

Who this might be right for
Human Immunodeficiency Virus
Oslo University Hospital 20
Post-approval studies (Phase 4)Study completedNCT04485325
What this trial is testing

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Who this might be right for
Rheumatic Arthritis
Dr. Frank Behrens 92
Testing effectiveness (Phase 2)Study completedNCT01001338
What this trial is testing

Allopurinol Combination Study

Who this might be right for
Gout
Ardea Biosciences, Inc. 227
Large-scale testing (Phase 3)Study completedNCT01510158
What this trial is testing

Combining Lesinurad With Allopurinol in Inadequate Responders

Who this might be right for
Gout
Ardea Biosciences, Inc. 607
Testing effectiveness (Phase 2)Active Not RecruitingNCT07015983
What this trial is testing

CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Large-scale testing (Phase 3)Looking for participantsNCT05749822
What this trial is testing

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases 104
Large-scale testing (Phase 3)Study completedNCT04333771
What this trial is testing

Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Jiangsu HengRui Medicine Co., Ltd. 566
Large-scale testing (Phase 3)Study completedNCT02222493
What this trial is testing

PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 650
Testing effectiveness (Phase 2)UnknownNCT04512339
What this trial is testing

Dupilumab in Severe Chronic Hand Eczema

Who this might be right for
Hand Eczema
University Medical Center Groningen 30
Large-scale testing (Phase 3)Study completedNCT05814627
What this trial is testing

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 487
Large-scale testing (Phase 3)UnknownNCT02823366
What this trial is testing

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Who this might be right for
Primary Biliary Cirrhosis
Xijing Hospital of Digestive Diseases 104
Testing effectiveness (Phase 2)Ended earlyNCT04423757
What this trial is testing

A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

Who this might be right for
Depressive Disorder, Major
Boehringer Ingelheim 45
Large-scale testing (Phase 3)Study completedNCT04856891
What this trial is testing

Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

Who this might be right for
Eosinophilic DuodenitisEosinophilic Gastroenteritis
Allakos Inc. 94
Testing effectiveness (Phase 2)Study completedNCT02833350
What this trial is testing

Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 578
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation